Sinomenine Protects against Early Brain Injury by Inhibiting Microglial Inflammatory Response via Nrf2-Dependent

Chuanjing Fu1, Heng Xin2, Zhengting Qian2

  • 1Department of Neurosurgery, Jiangsu Hospital of Traditional Chinese Medicine, Nanjing 210029, China.

Brain Sciences
|May 27, 2023
PubMed

Insights

Sinomenine (SIN) protects against early brain injury after subarachnoid hemorrhage (SAH) by reducing inflammation. It achieves this by activating the Nrf2 pathway, upregulating protective proteins, and inhibiting microglial activation.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Early brain injury (EBI) following subarachnoid hemorrhage (SAH) involves microglial activation and sustained inflammation.
  • Sinomenine (SIN) shows neuroprotective effects in traumatic brain injury (TBI) models, but its role in SAH-induced EBI is unclear.

Purpose of the Study:

  • To investigate the protective role of SIN in SAH-induced EBI.
  • To elucidate the effects of SIN on microglial inflammatory responses and the underlying mechanisms.

Main Methods:

  • SAH model in rats.
  • Assessment of neurological function (mNSS), brain edema, and neuronal apoptosis (Nissl staining).
  • Evaluation of Nrf2 pathway activation (Western blot, immunofluorescence), downstream proteins (HO-1, NQO-1 via IHC, RT-qPCR), and inflammatory markers (NF-κB, IL-1β, IL-6).

Main Results:

  • SIN administration improved neurobehavioral scores, reduced brain edema, and attenuated neuronal apoptosis post-SAH.
  • SIN inhibited microglial activation and inflammatory responses.
  • SIN upregulated HO-1 and NQO-1 expression, indicating Nrf2 pathway activation.

Conclusions:

  • SIN exerts neuroprotection against SAH-induced EBI.
  • SIN mitigates neuronal apoptosis by regulating microglial inflammatory responses, potentially via the Nrf2 pathway.